Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Oblique Therapeutics is delighted to announce the appointment of Christer Nordstedt M.D. PhD . as Chief Executive Officer.

Gothenburg, Sweden,9 November 2022 – Oblique Therapeutics AB (publ.), a biotechnology company focused on new antibody medicines for severe diseases with large unmet medical needs, is pleased to announce the confirmation of Christer Nordstedt MD.PhD. as Chief Executive Officer (CEO). Christer Nordstedt will assume the position on 1[st] December 2022.Christer Nordstedt has abroad and extensive international experience within the pharmaceutical industry from operational and strategic positions at management level in companies like Vivesto, Teva Pharmaceuticals, Orion Corporation, Eli Lilly,

Gapwaves publishes Interim Report for July - September 2022

Strong net sales growthThird quarter: 1 July – 30 September 2022 (Parent company)  · Net sales amounted to MSEK 30.9 (MSEK 8.5)   · EBITDA amounted to MSEK 6.3 (MSEK –7.9)   · Net result amounted to MSEK 5.9 (MSEK –9.2) corresponding to SEK 0.19 (SEK -0.30) per share   · Cash flow for the period was MSEK –4.3 (MSEK –12.4) and cash and cash equivalents at the end of the period amounted to MSEK 178 During Q3, the net sales revenue was MSEK 30.9, a growth of 261% compared to the same period in 2021. The revenue was MSEK 53 year-to-date. Q3 was a profitable quarter, with an

Q3 Update: Trophy Games increases YoY revenue with 24% and YoY EBITDA with 191%

Company Announcement No. 10-2022 Copenhagen, 9 November 2022   Highlights Q3 · Group revenue Q3 2022 was DKK 12.1m, which is 24% higher than Q3 2021. · Group EBITDA Q3 2022 was DKK 2.0m, which is 191% higher than Q3 2021. · Unique paying users total Q3 2022 was 43,454, which is 20% higher than Q3 2021. · Total transactions Q3 2022 was 143,891, which is 15% higher than Q3 2021. · Total installs Q3 2022 was 1.8m, which is 22% higher than Q3 2021. Year to date · Group revenue YTD 2022 was DKK 38.1m, which is 37% higher than the same period in 2021. ·

Betsson AB's Nomination Committee for the Annual General Meeting 2023

The Nomination Committee of Betsson AB (publ) for the Annual General Meeting 2023 has been appointed based on the ownership structure as of 31 August 2022.   The Nomination Committee consists of: Jenny Rosberg, appointed by Hamberg Förvaltning AB Mats Axell, appointed by Knutsson Holdings AB Karin Källström, appointed by Berit Lindwall   The Annual General Meeting 2023 of Betsson AB will be held on Wednesday, 10 May 2023.   Shareholders who would like to make proposals to the Nomination Committee may do so by email to info@betssonab.com or by post to Betsson AB,

Unibet signs partnership with Dutch cycling team Tour de Tietema

Unibet signs a partnership with Dutch cycling team Tour de Tietema. As of 1 January 2023, Kindred’s flagship brand Unibet will be the main sponsor of TDT-Unibet Cycling Team. The new team will start on the continental level but has the ambition to achieve the ProTeam status in the future.Kindred Group plc (Kindred) and its flagship brand Unibet enters a commercial partnership with Tour de Tietema in the Netherlands and Belgium. In addition to a commercial partnership, Tour de Tietema and Unibet will work together to inspire sports enthusiasts to start cycling themselves. Increasing social

Episurf Medical invites to a Capital Markets Day, November 16, 2022

EPISURF MEDICAL AB invites investors, analysts and media to a Capital Markets Day in Stockholm on Wednesday, November 16, 2022 at 13.00-16.00. Presentations will be held by members of Episurf Medical’s management group and customers, focusing on the company’s global commercial opportunities and strategy for the coming years. Presenters will be CEO Pål Ryfors, COO Katarina Flodström, President of Episurf Medical Inc. Patrick Jamnik, and Head of Sales OUS Stephen Caswell. They will be joined by Associate Professor Tim Spalding who is involved in studies on the Episealer® technology, and

TF Bank: Monthly statistics October 2022

The total loan portfolio amounted to SEK 13,938 million at the end of October. Compared to October 2021, the loan portfolio has increased by 28 % in local currencies.  Month Oct-22 Oct-21 ChangeConsumer Lending   New lending, SEK million 506 446 13 %Credit Cards   New lending, SEK million 566 242 134 %Ecommerce Solutions   Transaction volume*, SEK million 881 735 20 %  Cumulative for the year Jan-Oct 22 Jan-Oct 21 ChangeConsumer Lending   New lending, SEK million

Strong interest in Ortoma's new 3D modelling concept

Ortoma AB (publ) (”Ortoma” or the ”Company”) today announces that the Company's proof-of-concept presentations of the new technology for converting 2D x-ray images into 3D models, in conjunction with the annual meeting of the American Association of Hip and Knee Surgeons ("AAHKS"), were very successful. The Annual Meeting, which brings together leading orthopedic professionals, was held in Dallas, USA on 4-5 November 2022.Ortoma announced on October 31, 2022, that the Company would present a proof-of-concept solution for converting 2D x-ray images into 3D models built on the Company's

Notice of Extraordinary General Meeting in Swedish Stirling AB (publ)

The shareholders of Swedish Stirling AB (publ), Reg. No 556760-6602, are hereby invited to the Extraordinary General Meeting on 28 November 2022.The Board of Directors has decided that the Extraordinary General Meeting (the “EGM”) is to be held only through postal voting in accordance with temporary legislation. This means that the EGM will be conducted without the physical presence of shareholders, representatives or external parties and that shareholders will only be able to exercise their voting rights by postal voting in advance of the EGM in the manner described below. A. RIGHT TO

Interim Report Q3 – July – September, 2022 Redsense Medical AB (publ)

Focus ahead as US purchasing patterns burden Q3 July – September 2022 · Net sales amounted to kSEK 1,023 (3,566), a decrease of 71.3 percent. · Operating loss, EBIT amounted to kSEK 5,857 (2,852). · Result after tax amounted to kSEK -2,372 (-2,547). · Earnings per share was SEK -0.23 (-0.18) before and after dilution. January – September 2022 · Net sales amounted to kSEK 6,077 (6,008), an increase of 1 percent. · Operating loss, EBIT amounted to kSEK 10,506 (9,218). · Result after tax amounted to kSEK -6,205 (-6,937). · Earnings per share was SEK -0.50 (-0.

Boston Medical Center selects Sectra Enterprise Imaging for radiology, breast imaging and orthopaedics

Linköping, Sweden and Shelton, CT – November 9, 2022 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has signed a contract with Boston Medical Center (BMC) for enterprise imaging as a subscription (Sectra One). The solution has the capability of supporting all current and future imaging needs through a common platform with advanced diagnostic and clinical tools, integrated with Epic.The contract, signed in September 2022, includes modules for radiology, breast imaging, and orthopaedics. Additionally, the Sectra VNA will archive all

Interim Report Third Quarter 2022

STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENO STENOCARE A/S (“STENOCARE”) today announces its results for the period 01.01.2022 – 30.09.2022. The report, which has not been reviewed by the Company’s auditors, is attached to this release and is also available on https://stenocare.com/investor-relations/Thomas Skovlund Schnegelsberg, CEO of STENOCARE, comments: Q3 2022 marked several milestones that will help us grow sales and our leadership role during 2023 and onwards. We entered two new countries with medical cannabis oil products, we had another product

2020 Bulkers Ltd. (2020) – Commercial update and key information relating to the cash distribution for October 2022

Oslo, Norway, November 9, 2022 Commercial update: In October 2022, the Company achieved average time charter equivalent earnings of approximately US$26,700 per day, gross. The Company’s five vessels trading on index-linked time charter earned approximately US$25,100 per day, gross, including average daily scrubber benefits of approximately US$2,600 per day. The Company’s three vessels trading on fixed time charter earned approximately US$28,900 per day, gross, including average daily scrubber benefits of approximately US$3,700 per day. The Baltic 5TC Capesize Index averaged US$17,

2020 Bulkers Ltd. (2020) - Results for the third quarter of 2022

Oslo, Norway, November 9, 2022 2020 Bulkers Ltd. (“2020 Bulkers” or the “Company”), today announced its unaudited financial and operating results for the three and nine months ended September 30, 2022. Key events during the third quarter of 2022 · The Company reported net profit of US$7.3 million and EBITDA of US$12.7 million for the third quarter of 2022. · Achieved average time charter equivalent earnings of approximately US$25,800 per day, gross. · The Company declared total cash distributions of US$0.30 per share for the months of July, August and September 2022.

FDA Advisory Committee recommends PT027 in asthma

9 November 2022 07:00 GMT PT027 recommended by FDA advisory committee as new rescue treatment for asthma First and only rescue medication recommended for US approval that has been shown to reduce severe exacerbations The Food and Drug Administration's (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) has voted 16 to 1 that the data support a favourable benefit risk assessment for the use of PT027 (albuterol/budesonide) for the treatment of asthma in people aged 18 years and older. In adolescents aged 12 to 17 years, the Committee voted 9 to 8 that the data do not support a

Invitation to presentation of Catena Media’s Q3 results 2022

Catena Media’s interim report for the third quarter that ended 30 September 2022 will be published in English on Thursday 17 November at 07:00 CET. Following the report’s release, a combined presentation audiocast and telephone conference with the opportunity to ask questions will be held at 10:00 CET on the same day, with CEO Michael Daly and Group CFO Peter Messner presenting the report. The audiocast will be accessible via the following link:https://ir.financialhearings.com/catena-media-q3-2022 The presentation will also be available on the company’s website:https://www.

Interim report 1 January – 30 September 2022

Halmstad, 9 November 2022third QUARTER (1 July – 30 September 2022) · Net sales for the quarter amounted to MSEK 917 (180). · Operating profit before depreciation and amortisation (EBITDA) totalled MSEK 713 (76). · Operating profit (EBIT) totalled MSEK 697 (61). · Profit before tax, before items affecting comparability totalled MSEK 722 (57), and after items affecting comparability MSEK 705 (54). · Profit after tax amounted to MSEK 705 (54), or SEK 15.86 (1.41) per share. · Operating cash flow was MSEK 792 (93) and cash flow after investments amounted to MSEK 659 (64).

Karnov Group reports third quarter results 2022

Extraordinarily strong growth and all clear for European expansionFinancial highlights third quarter · Net sales increased by 18.4% to SEK 263 m (222), organic growth was 13.2% and acquired growth accounted for 2.4%. Currency effect was 2.8%. · EBITA amounted to SEK 85 m (80) with EBITA margin of 32.4% (36.1%). Items affecting comparability amounted to SEK 8 m (8). · Adjusted EBITA amounted to SEK 93 m (88) with adjusted EBITA margin of 35.3% (39.5%). · Net result amounted to SEK 50 m (23). · Earnings per share before and after dilution amounted to SEK 0.46 (0.24). ·

EQT Ventures III closes Europe's largest venture capital fund committed to early-stage tech startups

· EQT Ventures III holds final close at EUR 1 billion of fee-generating commitments, and EUR 1.1 billion of total commitments, to invest in European and North American early-stage tech startups  · The Fund, which includes participation from a wide range of European, North American and Asian institutional investors, foundations, and endowments, will make investments of EUR 1-50 million in founder-led startups using technology to try and solve some of the biggest challenges facing society  · EQT Ventures III brings total commitments raised across the EQT Ventures Funds to EUR 2.3

Last day of subscription of units in DanCann Pharma A/S ongoing rights issue and guidance on how to subscribe

COPENHAGEN, Denmark, November 09, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that Friday, November 11th, 2022, is the last day for subscription in DanCann Pharma’s ongoing rights issue of units of approximately DKK 28.5 million (the "Rights Issue").The last day of trading in unit rights on Spotlight Stock Market is today, the 9th of November 2022. Note that some banks and brokers have an earlier date for subscription than the 11th of November. Current shareholders or new investors should therefore

Huayou Cobalt awards tailings filtration equipment order to Metso Outotec

Metso Outotec Corporation’s press release on November 9, 2022, at 09:00 a.m. EETMetso Outotec has been awarded a repeat order to deliver sustainable tailings filtration technology for Zhejiang Huayou Cobalt Co. Ltd.’s new laterite nickel mine project in Indonesia. The order value, which is not disclosed, has been booked in Minerals fourth-quarter 2022 orders received. Metso Outotec’s scope of delivery consists of the engineering, manufacturing and supply of 15 Larox® FFP3512 filters, as well as installation and commissioning advisory services and spare parts. The fully automatic, fast-

Property transaction between Balder and Circle K enables 1,000 new homes and the opportunity for Circle K to test new ideas in central Kungsbacka

Fastighets AB Balder has acquired a property of approximately 4,600 sqm from Circle K and is a step closer to realising the Sydöstra Centrum urban development project in Kungsbacka. The building plans include housing, commercial premises and the possibility to establish a new type of fossil-free fuel station in central Kungsbacka.Through the Sydöstra Centrum area, Balder wants to create a modern, attractive and natural extension of Kungsbacka town centre. Circle K recently sold its share of the land to Balder but it has no plans to leave the area. Instead the establishment is planned at the

Neste to offer public electric vehicles charging service at its stations in Finland to complement its portfolio of solutions to reduce transport emissions

Neste Corporation, Press Release, 9 November 2022 at 9.00 a.m. EETNeste is introducing public high power charging (HPC) at its service stations in Finland for light and medium-duty electric vehicles. Neste MY Renewable Charging™ adds another option to Neste’s portfolio of solutions in Finland for supporting the transition to low-emission transport.  Serving both business and consumers, Neste’s first public high power charging stations will become available at the turn of the year at Neste Hankasalmi Jari-Pekka and Neste Oulunbaari Maikkula service stations. Furthermore, Neste

Swedish Stirling AB: Q3, 2022 report

Swedish Stirling AB publishes its Q3, 2022 report today.Swedish clean tech company Swedish Stirling AB is publishing its interim report for the period 01-07-2022 – 30-09-2022 today. The report is available for download in its entirety on the company’s website. Significant events during the period include the following: · Net sales for the quarter amounted to TSEK 39 (TSEK 50). Total revenue and capitalized work for the quarter was TSEK 39 (TSEK 10,666). · Earnings per share, before dilution, for the quarter was SEK -1.90 (SEK -0.13). · The Board of Directors of Swedish

There are no items matching the current filter
There are no more items matching the current filter
Back to top